Published in Cancer Weekly, November 15th, 1999
"Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is part of a signaling cascade stimulated by cell adhesion, motility, and growth. This tyrosine kinase, pp125FAK, initially was found to be tyrosine-phosphorylated in response to integrin-mediated cell adhesion, integrin clustering, and cell migration. Subsequently, FAK has been found to be activated by three oncoproteins: v-Sra, v-Crk, and Bar-Abl. Immunofluorescence studies indicate that the pp125FAK protein is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.